Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway

Jung-Soon Mo1, Zhipeng Meng1, Young Chul Kim2

  • 1Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, USA.

Nature Cell Biology
|March 10, 2015
PubMed

Insights

Cellular energy stress activates AMPK, which inhibits the Hippo-YAP pathway by phosphorylating YAP. This finding reveals a new mechanism linking energy status to cancer cell growth and YAP activity.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Hippo-YAP pathway regulates cell growth and organ size, and its dysregulation is implicated in cancer.
  • Yes-associated protein (YAP) is a key co-activator in this pathway, promoting gene expression through interaction with TEAD transcription factors.
  • YAP activity is normally controlled by the kinase Lats, which phosphorylates YAP, leading to its degradation.

Purpose of the Study:

  • To investigate the role of cellular energy status in regulating the Hippo-YAP pathway.
  • To elucidate the molecular mechanisms by which energy stress affects YAP activity.
  • To explore the potential of targeting this pathway for cancer therapy.

Main Methods:

  • Investigated the effect of cellular energy stress on YAP phosphorylation and activity.
  • Utilized biochemical assays to determine the interaction between AMPK, Lats, and YAP.
  • Assessed the impact of AMPK-mediated YAP inhibition on oncogenic transformation in cancer cells.

Main Results:

  • Cellular energy stress triggers YAP phosphorylation via AMPK-dependent Lats activation, inhibiting YAP.
  • AMP-activated protein kinase (AMPK) directly phosphorylates YAP at Serine 94, disrupting YAP-TEAD interactions.
  • AMPK-induced YAP inhibition suppresses the oncogenic transformation of Lats-null cells with elevated YAP activity.

Conclusions:

  • AMPK acts as a crucial link between cellular energy status and the Hippo-YAP pathway.
  • AMPK-mediated YAP inhibition represents a novel mechanism to suppress cancer progression.
  • Targeting the AMPK-YAP axis could offer therapeutic strategies for cancers with dysregulated Hippo-YAP signaling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K